YD Bio Ltd (YDES)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 29, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has notified YD Bio Ltd that it will not review their registration statement filed on September 23, 2025. The correspondence emphasizes the company's responsibility for th… | Read Filing EDGAR |
| Jul. 16, 2025 | CORRESP | Neutral/Informational | Moderate | YD Bio Limited has submitted a request to the U.S. Securities and Exchange Commission to accelerate the effective date of their Registration Statement on Form F-4. They are seekin… | Read Filing EDGAR |
| Jul. 10, 2025 | CORRESP | Neutral/Informational | Moderate | YD Bio Ltd submitted a response to the SEC's comment letter regarding Amendment No. 7 to their Registration Statement on Form F-4. The company acknowledged the SEC's concerns abou… | Read Filing EDGAR |
| Jul. 9, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed the amended registration statement for YD Bio Limited and issued comments requiring further clarification and amendments. Specifically, they have raised conce… | Read Filing EDGAR |
| Jul. 7, 2025 | CORRESP | Neutral/Informational | Low | YD Bio Ltd has submitted a response to the SEC's comment letter regarding Amendment No. 7 to their Registration Statement on Form F-4, filed on June 30, 2025. The company has ackn… | Read Filing EDGAR |
| Jul. 3, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed the amended registration statement for YD Bio Limited and has issued comments requiring further clarification and amendments. Specifically, the SEC is concern… | Read Filing EDGAR |
| Jun. 30, 2025 | CORRESP | Neutral/Informational | Moderate | YD Bio Ltd has submitted a response to the SEC's comment letter regarding their Amendment No. 6 to Registration Statement on Form F-4. The correspondence addresses several points … | Read Filing EDGAR |
| Jun. 18, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed YD Bio Limited's amended registration statement and provided several comments that require clarification and reconciliation regarding the Breast Cancer Licens… | Read Filing EDGAR |
| Jun. 4, 2025 | CORRESP | Neutral/Informational | - | No summary returned. | Read Filing EDGAR |
| May. 15, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed YD Bio Limited's Amendment No. 5 to their Registration Statement on Form F-4 and has provided a series of comments that require clarification and additional i… | Read Filing EDGAR |
| Apr. 30, 2025 | CORRESP | Concern from SEC | Moderate | The correspondence from YD Bio Ltd to the SEC addresses multiple comments regarding their Amendment No. 4 to Registration Statement on Form F-4. The SEC has requested more detaile… | Read Filing EDGAR |